To compare the levels of end-tidal carbon monoxide (ETCOc) among women with and without uterine contractions in term and preterm pregnancies.
INTRODUCTION
Spontaneous preterm birth is a major factor contributing to perinatal mortality and morbidity. 1 Despite extensive efforts to predict preterm delivery, parameters such as digital cervical examination, cervical length measured by transvaginal ultrasound and determination of fetal fibronectin in cervical secretions are only of limited value. [1] [2] [3] The inability to predict preterm birth may be attributed to various mechanisms responsible for the change in the quiescent state of the uterus at the time of labor. It is not fully understood as to why during most of the pregnancies, despite progressive stretching of the uterine wall as the fetus grows, the myometrial muscle does not forcefully contract, and lead to labor. One of the suggested mechanisms of uterine relaxation is the endogenous pathway by which nitric oxide (NO) causes increase in Guanosine 3 0 ,5 0 -cyclic monophosphate (cGMP) that leads to the relaxation of uterine smooth muscle cells during pregnancy. [4] [5] [6] However, in the guinea-pig it was demonstrated that pregnancy increases myometrial cGMP by a pathway independent of NO. 7 Carbon monoxide (CO) similar to NO, activates soluble guanylate cyclase leading to an increase in intracellular cGMP. 4 CO has been implicated in vascular smooth muscle relaxation and blood pressure regulation in rats. 8, 9 Acevedo et al 10 have demonstrated a 16-fold increase in the level of heme oxygenase (HO), the enzyme responsible for endogenous production of CO, in the pregnant uterus. Therefore, CO may play a role in smooth muscle contractile physiology and the maintenance of uterine quiescence during pregnancy.
The purpose of this study was to measure endogenous CO production during uterine contractions. Endogenous CO production was assessed by measuring end-tidal breath CO (ETCO) levels in pregnant women at term, or preterm gestation with and without uterine contractions.
MATERIALS AND METHODS
In all, 55 nonsmoking women were enrolled. The study group included 10 pregnant women with preterm contractions (PTC) (r34 weeks gestation) and 13 women in active labor (Z35 weeks). PTC were defined as three uterine contractions per 10 minutes or more, measured by external tocometry, associated with: pelvic or abdominal pressure, cramps, increased vaginal discharge and/or cervical change. The study groups were compared to 32 pregnant women with no complaints or evidence of contractions (34-41 weeks gestation).
Exclusion criteria included: smoking, respiratory illness, high blood pressure, pregnancy induced hypertension, chronic hypertension or HELLP (hemolysis, elevated liver enzymes, low platelets) syndrome, exposure to a known hemolytic agent, fever or evidence of an infectious disease, and any other significant medical illness, such as diabetes mellitus, fetal anomalies, IUFD, nonreassuring fetal status and IUGR. All women gave an informed consent for their participation. The institution's human investigation review board at the Sheba medical center approved the study.
End-tidal CO measurements corrected for ambient CO (ETCOc) were obtained and analyzed with a portable automated CO analyzer (Natus CO-Stat End Tidal Breath Analyzer; Natus Medical Inc., San Carlos, CA, USA). 11, 12 Each woman had a rest period of 15 minutes or more, then a 5F catheter was placed 2 cm into the nostrils. Samples were collected during 30 seconds of regular breathing and automatically averaged and analyzed by the analyzer.
Statistical analysis was performed using a two-way nonpaired Student's t-test, a one-way analysis of variance and Fisher's exact tests where appropriate. Pearson's product moment correlation test was used to evaluate the association between gestational age and ETCO measurements. A P-value <0.05 was considered significant.
RESULTS
Maternal characteristics including mean age, gravidity and parity, were not different between groups. The term labor group (39.8±1.8 weeks, mean±SD) and the control group (39.7±1.6 weeks), (P ¼ 0.9) had a later gestational age at the examination compared to the PTC group (29.4±3.3 weeks) (P<0.001).
ETCOc levels were significantly lower in both study groups compared with the control group (0.99±0.35 and 1.15±0.34 p.p.m.(P ¼ 0.48), vs 1.7±0.52 p.p.m., P<0.002) (Figure 1 ). In all, 70% of women with PTC and 61.5% of those with contractions in late gestation had ETCOc levels r1.2 p.p.m., compared with only 15.6% of the control group (P<0.05) (Figure 2 ). All women with PTC and all but one, of the women with contractions at late gestation, had ETCOc values r1.6 p.p.m., compared with only one-third of the women in the control group (P<0.03) (Figure 2 ). The gestational age at delivery was 37.9±2.2 weeks for the PTC group compared to 40.4±1.6 weeks for the patients in active labor at term.
COMMENT
We found that pregnant women who have contractions either preterm or term, had significantly lower levels of ETCOc compared to nonlabor gravida at late gestation (P<0. 002). Furthermore, ETCOc levels of 1.2 to 1.6 p.p.m. or less were associated with the presence of uterine contractions.
Our results are supported by previous findings regarding a possible role for CO in the mechanisms responsible for the quiescence of the myometrium.
11-14 CO like NO increases cGMP and is generated by HO, a microsomal enzyme that oxidatively cleaves heme, a pro-oxidant, to produce biliverdin and CO in the presence of NADPH-cytochrome P450 reductase and NADPH.
11
There are three isoforms of HO, that are regulated under separate mechanisms. The best-characterized isoforms, HO-1, which is inducible, and HO-2, which is constitutive, are immunologically distinct. 12 Acevedo et al 10 have shown that the activation of the HO-CO pathway by hemin (HO inducer), completely inhibited spontaneous contractility. In the pregnant rat, uterine and placental expression of HO and HO-1 mRNA levels increase during pregnancy up to day 16 of the 22 day-long rat gestation, and then decreases towards delivery. 13 These observations may indicate that induction of HO expression in the human and rat myometrium produces CO that limits uterine contractility. In one study, no quantitative difference was found in the amount of HO-2 protein in nonpregnant, nonlaboring, laboring, and preterm myometrium. No HO-1 protein was detectable by Western blotting in any of the groups studied. This was confirmed with immunohistochemistry data, which showed little or no HO-1 protein in any of the myometrial samples studied. 15 The contradicting results may be attributed to technical differences in the methods used in the above studies. [13] [14] [15] The major, and almost the sole, endogenous source of CO is a product of the HO catalyzed conversion of heme to bilirubin and CO. This production can be increased when hemolysis occurs, because hemoglobin degradation is the only metabolic pathway that produces significant amounts of this gas. 18 Elevated levels of ETCOc are found in women exposed to cigarette smoke. 19 Significantly lower levels of ETCOc were observed among women with high blood pressure or pre-eclampsia. 20, 21 Such women were excluded from the present study. Thus, the results we found probably represent the intrinsic production of CO.
We have found that the women who experience contractions have a lower rate of CO production, thus, less activation of the HO pathway that may result in a lower quiescence of the myometrium. We hypothesized that one possible explanatory mechanism may be a direct effect of CO through cGMP to relax the uterus. Soluble guanylyl cyclase (sGC) (a precursor of cGMP) activity in the myometrium, which is normally stimulated by NO and CO, was greater in myometrium from preterm (nonlabor) deliveries compared to those taken at term (in labor), but was downregulated compared with the activity in nonpregnant myometrium.
14 Other contributing mechanisms may include the fact that CO employs high levels of cytochrome P450, and by this may lower its quantity, thereby reducing the levels of substances responsible for vasoconstriction and possibly muscle contractions. A third potential explanatory mechanism is by a direct positive action on the calcium-dependent potassium channels that relax smooth muscle. 4, 22, 23 However, longo et al 4 found that even though hemin was able to completely inhibit uterine contractility in vivo in strips of term uterine myometrium, CO did not have the same effect and they hypothesize that the HO pathway may influence uterine contractility through a different mechanism while CO may only be a by-product of this process.
Recently, it was shown that 17-a hydroxyprogesterone can reduce the rate of recurrent preterm birth from 54% to 36%. 16 Iams 17 therefore suggested that progesterone may be effective in preventing preterm birth. Acevedo et al. 10 found that, exposure to progesterone, but not estradiol-17, induced the expression of HO-1 and HO-2 mRNAs. Progesterone also significantly induced HO-1 protein synthesis and CO production was stimulated by progesterone. These results suggest that the HO-CO cGMP pathway may be one of the mechanisms that mediate the effect of progesterone to prevent recurrent preterm birth.
The possible physiological role of HO pathway in maintenance of uterine quiescence during pregnancy deserves further study. Even though 90% of our preterm patients did not have a preterm birth, larger samples are needed in order to asses if measurement of ETCOc may be of value in the clinical assessment of PTC, and a future aid in the prediction of preterm delivery.
